Abstract

Mechanical circulatory support devices have become essential tools in the management of refractory cardiogenic shock. Impella RP® (Abiomed, Danvers, MA) is an FDA-approved device that provides minimally invasive support for right ventricular failure. As recognition of cardiogenic shock becomes more prevalent, there is an expanded use of circulatory support devices such as the Impella RP®, necessitating a continued evaluation of complications related to its use.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.